サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1540817

ジェノタイピング市場レポート：製品・サービス、技術、用途、エンドユーザー、地域別、2024～2032年

Genotyping Market Report by Product and Service, Technology (Polymerase Chain Reaction, Capillary Electrophoresis, Microarray, Sequencing, Mass Spectrometry, and Others), Application, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 149 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ジェノタイピング市場レポート：製品・サービス、技術、用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のジェノタイピング市場規模は2023年に194億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに574億米ドルに達し、2024～2032年の間に12.5%の成長率（CAGR）を示すと予測しています。

ジェノタイピングとは、DNA配列を調べて、ヒト、植物、動物、微生物を含む生物の遺伝子型における遺伝的体質を決定する分析手順を指します。遺伝子試験では、生物学的アッセイによって遺伝的差異を検出することにより、DNA構造の変化や一塩基多型など、さまざまな遺伝的逸脱を調べることができます。この情報を利用することで、個体間の違いを比較することができ、同時に個人の遺伝歴に関連するデータを提供することができます。一方、ウイルスや細菌などの微生物の遺伝子型判定は、ウイルスや細菌性疾患の発生源を特定することで、病原体の拡散を防ぐのに役立ちます。

ジェノタイピング市場動向：

世界市場は、世界中の医療施設における遺伝子型ベースの診断試験に対する需要の高まりによって大きく牽引されています。この背景には、がんや遺伝性疾患を含む慢性疾患の有病率の増加があります。これに加えて、創薬・市場開拓プロセスにおけるデータ解析や薬理ゲノミクスにおけるバイオインフォマティクスソリューションの採用が増加していることも、市場成長の原動力となっています。さらに、ゲノム創薬や精密医療研究に焦点を当てた研究開発（R&D）活動への投資が大幅に増加していることも、市場を牽引しています。これとは別に、世界レベルでのジェノタイピング試験量の増加に伴う試薬需要の高まりも、市場に明るい展望をもたらしています。市場の成長に寄与しているその他の要因としては、多くの病状を開拓しやすい高齢者人口の増加、ジェノタイピング製品の継続的な技術進歩、大衆の間での個別化医療に関する意識の高まり、医療費の大幅な拡大などが挙げられます。

本レポートで扱う主要質問

  • 世界のジェノタイピング市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19は世界のジェノタイピング市場にどのような影響を与えたか？
  • 主要地域市場とは？
  • 製品サービス別の市場内訳は？
  • 技術別の市場内訳は？
  • 用途別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界のジェノタイピング市場の構造と主要参入企業は？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のジェノタイピング市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品・サービス別

  • 機器
  • 試薬とキット
  • ソフトウェアとサービス

第7章 市場内訳：技術別

  • ポリメラーゼ連鎖反応（PCR）
  • キャピラリー電気泳動
  • マイクロアレイ
  • シーケンシング
  • 質量分析
  • その他

第8章 市場内訳：用途別

  • 薬理ゲノム学
  • 診断と個別化医療
  • 農業バイオテクノロジー
  • 動物遺伝学
  • その他

第9章 市場内訳：エンドユーザー別

  • 製薬・バイオ医薬品企業
  • 診断と研究ラボ
  • 学術機関
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • Eurofins Scientific SE
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • Qiagen N.V
    • Standard BioTools Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Genotyping Market: Major Drivers and Challenges
  • Figure 2: Global: Genotyping Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Genotyping Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Genotyping Market: Breakup by Product and Service (in %), 2023
  • Figure 5: Global: Genotyping Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Genotyping Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Genotyping Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Genotyping Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Genotyping (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Genotyping (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Genotyping (Reagents and Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Genotyping (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Genotyping (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Genotyping (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Genotyping (Polymerase Chain Reaction (PCR)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Genotyping (Polymerase Chain Reaction (PCR)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Genotyping (Capillary Electrophoresis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Genotyping (Capillary Electrophoresis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Genotyping (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Genotyping (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Genotyping (Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Genotyping (Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Genotyping (Mass Spectrometry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Genotyping (Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Genotyping (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Genotyping (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Genotyping (Pharmacogenomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Genotyping (Pharmacogenomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Genotyping (Diagnostics and Personalized Medicine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Genotyping (Diagnostics and Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Genotyping (Agricultural Biotechnology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Genotyping (Agricultural Biotechnology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Genotyping (Animal Genetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Genotyping (Animal Genetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Genotyping (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Genotyping (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Genotyping (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Genotyping (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Genotyping (Diagnostics and Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Genotyping (Diagnostics and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Genotyping (Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Genotyping (Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Genotyping (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Genotyping (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: North America: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: North America: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: United States: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: United States: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Canada: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Canada: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Asia-Pacific: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Asia-Pacific: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: China: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: China: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Japan: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Japan: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: India: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: India: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: South Korea: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: South Korea: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Australia: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Australia: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Indonesia: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Indonesia: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Europe: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Europe: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Germany: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Germany: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: France: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: France: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: United Kingdom: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: United Kingdom: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Italy: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Italy: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Spain: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Spain: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Russia: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Russia: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Latin America: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Latin America: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Brazil: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Brazil: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Mexico: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Mexico: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Others: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Others: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Middle East and Africa: Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Middle East and Africa: Genotyping Market: Breakup by Country (in %), 2023
  • Figure 93: Middle East and Africa: Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Global: Genotyping Industry: SWOT Analysis
  • Figure 95: Global: Genotyping Industry: Value Chain Analysis
  • Figure 96: Global: Genotyping Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genotyping Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Genotyping Market Forecast: Breakup by Product and Service (in Million US$), 2024-2032
  • Table 3: Global: Genotyping Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Genotyping Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Genotyping Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Genotyping Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Genotyping Market: Competitive Structure
  • Table 8: Global: Genotyping Market: Key Players
目次
Product Code: SR112024A5815

The global genotyping market size reached US$ 19.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 57.4 Billion by 2032, exhibiting a growth rate (CAGR) of 12.5% during 2024-2032.

Genotyping refers to an analytical procedure that examines DNA sequences to determine the genetic constitution in the genotypes of living organisms, including humans, plants, animals, and microorganisms. Genetic tests enable scientists to examine a variety of genetic deviations, such as changes in DNA structure and single nucleotide polymorphisms, by detecting genetic differences through biological assays. By using this information, the differences between individuals can be compared while providing data related to the genetic history of an individual. Genotyping of microorganisms, such as viruses and bacteria, on the other hand, helps prevent the spread of pathogens by pinpointing the source of viral and bacterial diseases.

Genotyping Market Trends:

The global market is majorly driven by the rising demand for genotypic-based diagnostic testing in healthcare facilities across the globe. This can be attributed to the increasing prevalence of chronic diseases, including cancer and genetic disorders. In addition to this, the rising adoption of bioinformatics solutions in data analysis and pharmacogenomics in the drug discovery and development processes is also providing an impetus to the market growth. The market is further driven by the substantial rise in investments in research and development (R&D) activities focusing on genomic drug development and precision medicine research. Apart from this, the escalating demand for reagents for the augmenting volumes of genotyping tests on the global level is creating a positive outlook for the market. Some of the other factors that are contributing to the growth of the market include the rising geriatric population that is susceptible to developing numerous medical conditions, continual technological advancements in genotyping products, the growing awareness regarding personalized medicines among the masses and a considerable expansion of healthcare expenditure.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global genotyping market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and service, technology, application and end user.

Breakup by Product and Service:

Instruments

Reagents and Kits

Software and Services

Breakup by Technology:

Polymerase Chain Reaction (PCR)

Capillary Electrophoresis

Microarray

Sequencing

Mass Spectrometry

Others

Breakup by Application:

Pharmacogenomics

Diagnostics and Personalized Medicine

Agricultural Biotechnology

Animal Genetics

Others

Breakup by End User:

Pharmaceutical and Biopharmaceutical Companies

Diagnostics and Research Laboratories

Academic Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Qiagen N.V, Standard BioTools Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global genotyping market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global genotyping market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product and service?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global genotyping market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genotyping Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents and Kits
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reaction (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Capillary Electrophoresis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Microarray
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Sequencing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Mass Spectrometry
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pharmacogenomics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostics and Personalized Medicine
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Agricultural Biotechnology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Animal Genetics
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical and Biopharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostics and Research Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bio-Rad Laboratories Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Danaher Corporation
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 Eurofins Scientific SE
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 F. Hoffmann-La Roche AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Illumina Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Laboratory Corporation of America Holdings
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Qiagen N.V
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Standard BioTools Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Thermo Fisher Scientific Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis